Literature DB >> 15630413

Galectins as modulators of tumour progression.

Fu-Tong Liu1, Gabriel A Rabinovich.   

Abstract

Galectins are a family of animal lectins with diverse biological activities. They function both extracellularly, by interacting with cell-surface and extracellular matrix glycoproteins and glycolipids, and intracellularly, by interacting with cytoplasmic and nuclear proteins to modulate signalling pathways. Current research indicates that galectins have important roles in cancer; they contribute to neoplastic transformation, tumour cell survival, angiogenesis and tumour metastasis. They can modulate the immune and inflammatory responses and might have a key role helping tumours to escape immune surveillance. How do the different members of the Galectin family contribute to these diverse aspects of tumour biology?

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630413     DOI: 10.1038/nrc1527

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  478 in total

1.  Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen.

Authors:  Lei Feng; Hui Sun; Ying Zhang; De-Feng Li; Da-Cheng Wang
Journal:  FASEB J       Date:  2010-06-07       Impact factor: 5.191

2.  Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention.

Authors:  Yuhua Li; Li Liu; Yinbo Niu; Juan Feng; Yang Sun; Xianghe Kong; Yongchun Chen; Xiaoyan Chen; Hongquan Gan; Shousong Cao; Qibing Mei
Journal:  Eur J Nutr       Date:  2011-04-24       Impact factor: 5.614

3.  The concept of spectral accuracy for MS.

Authors:  Yongdong Wang; Ming Gu
Journal:  Anal Chem       Date:  2010-09-01       Impact factor: 6.986

Review 4.  Early detection of myocardial dysfunction and heart failure.

Authors:  Geoffrey de Couto; Maral Ouzounian; Peter P Liu
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

Review 5.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

6.  Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies.

Authors:  Mariana Rodríguez Zubieta; David Furman; Marcela Barrio; Alicia Inés Bravo; Enzo Domenichini; José Mordoh
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer.

Authors:  Sayaka Yamaki; Takaaki Fujii; Reina Yajima; Tomoko Hirakata; Satoru Yamaguchi; Tomomi Fujisawa; Soichi Tsutsumi; Takayuki Asao; Yasuhiro Yanagita; Misa Iijima; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2012-10-23       Impact factor: 2.549

Review 8.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

Review 9.  Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.

Authors:  Vanessa Leiria Campo; Marcelo Fiori Marchiori; Lílian Cataldi Rodrigues; Marcelo Dias-Baruffi
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

10.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.